AAIS
TEVA icon

ABN AMRO Investment Solutions’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

ABN AMRO Investment Solutions’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Buy
+15,719
New +$524K ﹤0.01% 586

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

ABN AMRO Investment Solutions's TEVA Position: Q2 2026 in Review

ABN AMRO Investment Solutions opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 15,719 shares worth $533K. The stake represents ﹤0.01% of the portfolio and ranks #586 among its holdings.

676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • ABN AMRO Investment Solutions held 15,719 shares of Teva Pharmaceutical Industries Limited worth $533K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new ABN AMRO Investment Solutions position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of ABN AMRO Investment Solutions's portfolio in Q2 2026, its #586 holding.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on ABN AMRO Investment Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.